Congenital Disorders of Glycosylation Biomarkers
Increasing levels
- Glycan analysis of serum proteins, such as the Igs that collectively account for up to 50% of the serum glycoproteins, provides diagnostic information that can pinpoint the faulty step in the pathway.
Congenital Disorders of Glycosylation Biomarkers
Decreasing levels
- Decreased leveles of sialylated glycans.
References: